93 7456 (Glipizide and metformin hydrochloride 2.5 mg / 500 mg)
Pill imprint 93 7456 has been identified as Glipizide and metformin hydrochloride 2.5 mg / 500 mg.
Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 93 7456 (Glipizide and metformin hydrochloride 2.5 mg / 500 mg)
- 2.5 mg / 500 mg
- 17.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- Inactive Ingredients:
- corn starch
|NDC Code||Manufacturer / Repackager|
|00555-0626||Barr Laboratories Inc|
|00591-3972||Watson Pharmaceuticals, Inc. (now Actavis, Inc)|
Note: Inactive ingredients may vary.
More about glipizide/metformin
- Other brands: Metaglip
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...